Article Details

Simulation model shows potential clinical value of Eisai drug for patients with early AD

Retrieved on: 2022-09-29 07:31:14

Tags for this article:

Click the tags to see associated articles and topics

Simulation model shows potential clinical value of Eisai drug for patients with early AD. View article details on HISWAI: https://www.biopharma-reporter.com/Article/2022/05/09/Simulation-model-shows-potential-clinical-value-of-Eisai-drug-for-patients-with-early-AD

Excerpt

Lecanemab is an investigational humanized monoclonal antibody for Alzheimer's disease (AD) that is the result of a strategic research alliance ...

Article found on: www.biopharma-reporter.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up